Keratoconjunctivitis Sicca (KCS) (DBCOND0105777)

Identifiers

Synonyms
Kerato Conjunctivitis Sicca / Keratoconjunctivitis Sicca / Conjunctivitis sicca / Keratoconjunctivitis sicca (disorder) / Keratoconjunctivitis sicca, in Sjögren's syndrome (disorder) / Dry Eye / Dry eyes (finding) / Eyes dry / Dry eye NOS / Dryness of eyes / Dry eyes / Eye dryness

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Cyclosporine
A steroid-sparing immunosuppressant used in organ and bone marrow transplants as well as inflammatory conditions such as ulcerative colitis, rheumatoid arthritis, and atopic dermatitis.
Hydroxypropyl cellulose
A cellulose ether used to treat dry eyes.
No drug targets
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT03418259
Intra-Nasal Mechanical Stimulation (INMEST) as a Treatment of Keratoconjunctivitis Sicca (Dry Eye Syndrome)No drug interventionstreatmentNot Availablecompleted
NCT05848128
Efficacy and Safety Evaluation of Tavilermide Ophthalmic Solution for the Treatment of Dry Eyetreatment3completed
NCT03652415
DRy Eye Outcome and Prescription StudyNo drug interventionsNot AvailableNot Availableunknown_status
NCT05825352
PMCF Study to Evaluate Performance and Safety of "Ocular Drops Based Upon Carmellose" Used to Relieve Dry Eye SymptomsNo drug interventionstreatmentNot Availablecompleted
NCT03616899
Safety and Efficacy of KPI-121 in Subjects With DEDtreatment3completed
NCT05825586
PMCF Study to Evaluate Performance and Safety of "Distilled Waters-based Eyedrops" Used to Relieve Dry Eye SymptomsNo drug interventionstreatmentNot Availablecompleted
NCT05119920
Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Dry Eye Diseasetreatment2completed
NCT06329687
A Study Evaluating the Safety of the Nasal Pumptreatment4terminated
NCT06176651
Evaluation of Miebo (Perfluorohexyloctane) Eyedrops in Habitual Contact Lens Wearerstreatment4completed
NCT05823961
PMCF Study to Evaluate Performance and Safety of "CLHA-based Eyedrops" Used to Improve Lacrimal AbnormalitiesNo drug interventionstreatmentNot Availablecompleted
NCT03878628
Treatment With Allogeneic Adipose-derived Mesenchymal Stem Cells in Patients With Aqueous Deficient Dry Eye DiseaseNo drug interventionstreatment0completed
NCT05825599
PMCF Study to Evaluate Performance and Safety of "HPMC-based Eyedrops" Used to Relieve Dry Eye SymptomsNo drug interventionstreatmentNot Availablecompleted
NCT05807360
PMCF Study to Evaluate Performance and Safety of "Hyaluronic Acid (HA)-Based Eyedrops" Used to Relieve Dry Eye SymptomsNo drug interventionstreatmentNot Availablecompleted
NCT00407043
Multicenter, Randomized, Controlled Study of the Effect of Lotemax on Initiation of Dry Eye Treatment With Restasistreatment4completed
NCT04649177
Pilot Study to Investigate the Feasibility, Reliability and Efficacy of Utilizing OCT to Automate PROSE FittingNo drug interventionstreatmentNot Availablecompleted
NCT01057147
Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Subjects With Dry Eye - Effects on Central Corneatreatment2completed
NCT00128245
Safety and Efficacy of Pimecrolimus Ophthalmic Suspension in Patients With Moderate to Severe Keratoconjunctivitis Siccatreatment2completed
NCT01421498
Safety and Efficacy Study of SAR 1118 to Treat Dry Eye Conducted in a Controlled Adverse Environment (CAE) (OPUS-1)treatment3completed
NCT00848198
TearLab Core Validation Study to Establish Referent Values for Dry Eye DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT04421300
A Randomized Study of Smile Exercise for Dry EyetreatmentNot Availablecompleted
NCT02970799
Tear Production by Nasal Neurostimulation Compared to Active ControlNo drug interventionsotherNot Availablecompleted
NCT05918406
Phase 4 Study Evaluating the Safety of the Nasal Guide With TyrvayaNo drug interventionstreatment4completed
NCT01027013
Safety and Efficacy Study of Rebamipide 2% Ophthalmic Suspension in Patients With Dry Eyetreatment2completed
NCT00025818
Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrometreatment3completed
NCT01235234
Trial of CF101 to Treat Patients With Dry Eye Diseasetreatment3completed
NCT02665234
A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry Eye Diseasetreatment3completed
NCT01797822
Effects of Dry Eye Treatments on the Ocular Surfacetreatment4completed
NCT05618730
Safety, Tolerability, Plug Retention and Preliminary Efficacy of Tacrolimus-loaded Punctal Plug in Patients With Moderate to Severe Dry Eye Disease - Cohort BNo drug interventionstreatment1active_not_recruiting
NCT00349466
Safety and Efficacy Study of CF101 to Treat Keratoconjunctivitis Siccatreatment2completed
NCT02254265
Phase 2/3 Dose-Ranging Study of the Safety and Efficacy of OTX-101 in the Treatment of Keratoconjunctivitis SiccaNo drug interventionstreatment2 / 3completed
NCT00681265
Tear Film Break-up Time After Instillation of Artificial TearstreatmentNot Availablecompleted
NCT02845674
An Open-Label Extension of a Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis SiccaNo drug interventionstreatment3completed
NCT00411827
Goblet Cell Response and Dry Eye Symptoms After PRK and LASIKNo drug interventionstreatmentNot Availableunknown_status
NCT03925727
Tavilermide Ophthalmic Solution for the Treatment of Dry Eyetreatment3completed
NCT03436576
Efficacy of Two Concentrations of Autologous Serum for the Treatment of Severe Dry Eyetreatment3unknown_status
NCT02188160
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Diseasetreatment2completed
NCT01226680
A Study Of Tasocitinib In Dry Eye Subjectstreatment2withdrawn
NCT02798289
Acute Tear Production Following Single Use of the Oculeve Intranasal NeurostimulatorNo drug interventionssupportive_careNot Availablecompleted
NCT02121301
A Clinical Study to Assess the Safety and Efficacy of an Ophthalmic Solution (SkQ1) in the Treatment of Dry Eye Syndrome (DES)treatment2completed
NCT00201981
Study of Rebamipide Eye Drops to Treat Dry Eyetreatment3completed
NCT00201955
Study of Rebamipide Eye Drops to Treat Dry Eyetreatment3completed
NCT03706443
Tear Lipid Layer Thickness Changes With Use of Emollient and Non-Emollient Eye DropsNo drug interventionstreatmentNot Availablecompleted
NCT00426543
Effect of B-cell Depletion in Patients With Primary Sjögren's Syndrometreatment2completed
NCT03953703
Levocarnitine for Dry Eye in Sjogren's Syndrometreatment2recruiting
NCT02526290
Six Month Study to Evaluate the Safety and Effectiveness of the Intranasal Lacrimal NeurostimulatorNo drug interventionssupportive_careNot Availablecompleted
NCT02819284
Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Diseasetreatment3completed
NCT00554879
Acupuncture Treatment of Dry EyeNo drug interventionstreatmentNot Availablecompleted
NCT02117687
A Safety and Efficacy Study of OPTIVE FUSION™ With VISMED® Multi for the Management of Dry Eyetreatment4completed
NCT02139033
A Phase 4 Study Investigating the Efficacy of Retaine™ in Managing Signs and Symptoms Associated With Dry Eye SyndromeNo drug interventionstreatment4completed
NCT02634853
A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry Eyetreatment3completed
NCT00037661
Study of INS365 Ophthalmic Solution in a Controlled Adverse Environment in Patients With Dry Eyetreatment3completed
NCT03753893
Ocular Manifestations in Rheumatic DiseasesNo drug interventionsNot AvailableNot Availablecompleted
NCT02688556
Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Siccatreatment3completed
NCT03408015
Effects of Xiidra on Closed Eye Tear Film Leukocytes in Dry Eye Diseasebasic_science4withdrawn
NCT01213342
Omega-3 Fatty Acid Supplements and Dry EyeNo drug interventionstreatmentNot Availableterminated
NCT01900249
To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis SiccaNo drug interventionstreatment2completed
NCT00883649
Efficacy and Safety Study of Nutritional Supplements for Treatments of Dry EyeNo drug interventionstreatmentNot Availablecompleted
NCT01547936
Effect of Controlled Adverse Environment (CAE) on Tear Film StabilityNo drug interventionsNot AvailableNot Availablecompleted
NCT03398018
Repository Corticotropin Injection in Keratoconjunctivitis Siccatreatment4withdrawn
NCT00717418
Efficacy Study of Cyclosporine Ophthalmic Emulsion in Patients With Dry Eye DiseaseNot AvailableNot Availablecompleted
NCT00345241
Effects of Systane Versus Saline in Maintaining Tear Film Stability at Determined Time PointstreatmentNot Availablecompleted
NCT04884217
Treatment of Dry Eye Disease Using Pro-ocular™ - A Proof of Concept, Safety, and Efficacy StudyNo drug interventionstreatment2unknown_status
NCT00851734
A Dose-Escalation Study to Assess the Safety and Tolerability of LX214 Ophthalmic Solution in Healthy Volunteers, Followed by an Open-Label Evaluation of LX214 in Patients With Keratoconjunctivitis Sicca (KCS)treatment1completed
NCT02066896
Laser Therapy to Treat the Dry Mouth of Sjogren's SyndromeNo drug interventionstreatmentNot Availablecompleted
NCT04493658
Differential Diagnosis of Sjögren's Versus Non-Sjögren's Dry EyeNo drug interventionsNot AvailableNot Availablecompleted
NCT02680158
A Study to Evaluate the Safety and Effectiveness of Oculeve Intranasal Lacrimal Neurostimulator in Participants With Dry Eye SyndromeNo drug interventionssupportive_careNot Availablecompleted
NCT01102257
Dry Eye Assessment and Management: Feasibility Studytreatment2 / 3completed
NCT02813265
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Diseasetreatment3completed
NCT01817582
Lotemax® Gel 0.5% and Restasis 0.05% in Participants With Mild or Moderate Keratoconjunctivitis Sicca (Dry Eye Disease)treatment2completed
NCT00001731
Treatment of Dry Eye Syndrome With Cyclosporin A Eye Dropstreatment2completed
NCT00987727
Safety and Efficacy of Carboxymethylcellulose for Ocular Surface Integrity in Symptomatic Dry Eyetreatment4completed
NCT00788229
Efficacy and Safety Study of ATs in Patients With Dry Eye SyndromeNo drug interventionstreatment2completed
NCT01733992
A Safety, Tolerability and Pharmacokinetics Study of R932348 Eye Drops in Patients With Dry Eye DiseaseNo drug interventionstreatment1completed
NCT04147650
Dose Ranging Study to Assess the Efficacy and Safety of Voclosporin Ophthalmic Solution in Subjects With Dry Eye Syndrometreatment2 / 3completed